AGILON HEALTH INC (AGL)

US00857U1079 - Common Stock

1.85  -0.12 (-6.09%)

After market: 1.86 +0.01 (+0.54%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031
Revenue
YoY % growth
1.834B
50.50%
2.708B
47.70%
4.316B
59.38%
6.114B
41.65%
6.744B
10.30%
7.78B
15.36%
9.187B
18.08%
10.808B
17.64%
11.475B
6.17%
10.246B
-10.71%
11.384B
11.11%
EBITDA
YoY % growth
-379.33M
-790.45%
-106.63M
71.89%
-211.972M
-98.79%
-123.454M
41.76%
-48.223M
60.94%
25.28M
152.42%
109.28M
332.28%
211.75M
93.77%
161.7M
-23.64%
193.92M
19.93%
232.2M
19.74%
EBIT
YoY % growth
-394M
-594.89%
-120.4M
69.44%
-232.133M
-92.80%
-284.161M
-22.41%
-236.931M
16.62%
-137.227M
42.08%
-87.466M
36.26%
-44.036M
49.65%
-16.665M
62.16%
4.141M
124.85%
29.593M
614.63%
Operating Margin
-21.49%-4.45%-5.38%-4.65%-3.51%-1.76%-0.95%-0.41%-0.15%0.04%0.26%
EPS
YoY % growth
-1.07-0.26
75.70%
-0.49
-88.46%
-0.57
-16.52%
-0.39
30.82%
-0.23
41.61%
0.10
143.80%
0.37
270.00%
N/AN/AN/A

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth
-0.23
43.97%
-0.03
-240.07%
-0.08
-16.15%
-0.16
44.82%
-0.15
33.47%
-0.04
-18.80%
-0.06
25.47%
-0.01
93.69%
-0.07
53.74%
Revenue
Q2Q % growth
1.525B
44.40%
1.751B
9.14%
1.666B
12.36%
1.633B
12.55%
1.694B
11.08%
2.029B
15.88%
1.985B
19.15%
1.955B
19.72%
2.012B
18.77%
EBITDA
Q2Q % growth
-73.659M
47.18%
17.493M
1,411.32%
-1.78M
94.37%
-56.983M
50.68%
-47.638M
35.33%
-1.818M
-110.39%
1.919M
207.80%
20.301M
135.63%
-4.646M
90.25%
EBIT
Q2Q % growth
-103.645M
35.06%
6.952M
196.85%
-36.478M
15.84%
-70.599M
47.12%
-74.74M
27.89%
N/AN/AN/AN/A

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth
-0.29
-262.50%
-0.11-0.18-171.08%
Q2 2024
Q2Q % growth
-0.07
-75.00%
-0.080.0114.11%
Q1 2024
Q2Q % growth
-0.01
-125.00%
-0.010.0018.64%
Q4 2023
Q2Q % growth
-0.41
-192.86%
-0.30-0.11-34.90%
Q3 2023
Q2Q % growth
-0.08
-14.29%
-0.06-0.02-39.16%
Q2 2023
Q2Q % growth
-0.04
20.00%
-0.03-0.01-55.98%
Q1 2023
Q2Q % growth
0.04 0.020.0281.50%
Q4 2022
Q2Q % growth
-0.14 -0.09-0.05-61.18%
Q3 2022
Q2Q % growth
-0.07
22.22%
-0.05-0.02-38.61%
Q2 2022
Q2Q % growth
-0.05
93.67%
-0.02-0.03-175.03%
Q1 2022
Q2Q % growth
0.00
100.00%
0.000.00-100.00%
Q4 2021
Q2Q % growth
-0.14 -0.11-0.03-26.01%
Q3 2021
Q2Q % growth
-0.09 -0.100.017.82%
Q2 2021
Q2Q % growth
-0.79 -0.06-0.73-1,322.14%
Q1 2021
Q2Q % growth
-0.05 -0.03-0.02-65.02%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth
1.451B
19.35%
1.485B-34.068M-2.29%
Q2 2024
Q2Q % growth
1.483B
29.04%
1.575B-92.242M-5.86%
Q1 2024
Q2Q % growth
1.604B
41.21%
1.62B-15.646M-0.97%
Q4 2023
Q2Q % growth
1.056B
53.10%
1.028B28.073M2.73%
Q3 2023
Q2Q % growth
1.216B
74.94%
1.149B66.66M5.80%
Q2 2023
Q2Q % growth
1.149B
71.47%
1.122B27.052M2.41%
Q1 2023
Q2Q % growth
1.136B
73.88%
1.089B47.147M4.33%
Q4 2022
Q2Q % growth
689.8M
49.02%
671M18.8M2.80%
Q3 2022
Q2Q % growth
694.9M
51.53%
660.61M34.29M5.19%
Q2 2022
Q2Q % growth
670.1M
34.29%
654.46M15.64M2.39%
Q1 2022
Q2Q % growth
653.4M
58.17%
648.65M4.75M0.73%
Q4 2021
Q2Q % growth
462.9M 457.42M5.48M1.20%
Q3 2021
Q2Q % growth
458.6M
46.66%
454.85M3.75M0.82%
Q2 2021
Q2Q % growth
499M
69.96%
478.03M20.97M4.39%
Q1 2021
Q2Q % growth
413.1M
41.96%
409.55M3.55M0.87%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS-3.14% -32.9% -45.81% -60.28%
Revenue0.26% 3.11% 0.41% 0.51%